| Cat |
Author |
Title |
| A1 |
Maria Teresa Sandri |
Peri-operative circulating tumor cells detection in patients with primary breast cancer undergoing surgery |
| A2 |
Bint Mohamed Bin Amer Suad |
Gene expression profiling of breast tumors to identify age-spcific signatures and molecular characterization of cancer progression in Saudi females |
| A3 |
Anna Sapino |
Gene expression profiling in under-vacuum stored breast carcinomas: a pilot study |
| B1 |
Caroline Diorio |
Fibroblast growth factor receptor-2 polymorphisms, vitamin D and calcium intakes and mammographic breast density |
| C1 |
Eun-Young Park |
Is 18FDG-PET Ct available for detection of preopeartive axillary lymph node metastasisi in invasive ductal carcinoma? |
| C2 |
Immacolata Capasso |
An educational and informative program for breast cancer prevention: National Cancer Institute of Naples experience |
| D01 |
Augusto Lombardi |
Validation of two breast cancer nomograms for predicting non-sentinel nodes metastasis in positive sentinel node patients |
| D02 |
Vijay D. Devanhalli |
Outcome analysis of breast reconstruction with pedicled latissimus dorsi flaps in partial breast defects |
| D04 |
Valery V. Rodionov |
Segmental resection as a method of early breast cancer treatment |
| D05 |
Vasin Chotivanich |
Three-year follow-up of mastectomy with immediate LD flap reconstruction by the extended LD flap technique |
| D06 |
Youwanush Kongdan |
Immediate breast reconstruction with latissimus dorsi pedicle flap and prothesisi by using single cosmetic breast incision |
| D07 |
Thongchai Sukarayothin |
Nipple reconstruction using a local U-shaped flap and partial-thickness skin graft technique |
| D08 |
Kampol Ratchaworapong |
Variation in site of superior epigastric vessels. A guide to safe pedicled TRAM flap reconstruction |
| D09 |
Nicolaos Papadopulos |
Quality of life and patients' satisfaction after breast reconstruction |
| D10 |
Eun-Young Park |
Mammary myofibroblastoma: a case with vacuum-assisted breast biopsy |
| D12 |
Geraldo Sergio Vitral Farinazzo |
Polidimethylsiloxane (PDMS) as radiological contrast and tissue marker for ROLL: a new proposal |
| D13 |
Alberto Marassi |
Breast conserving surgery: the importance of intraoperative margin evaluation |
| D14 |
Jinnie Pang |
Sentinel lymph node biopsy for breast cancer: how many nodes to stop at? Our experience at a tertiary Centre in Singapore |
| D15 |
Pavlidou Foteini |
Atypical medial axillary arch found during axillary lymphadenectomy to cross over the axilla content |
| D16 |
Mitko Riostov |
Breast cancer in the Breast Unit at PHO Nirvana, Kocani, Macedonia |
| D17 |
Francesco Frattini |
Breast cancer surgery in an ambulatory setting |
| D18 |
Mario Vetrano |
Axillary web syndrome after sentinel node biopsy and axillary dissection in breast cancer |
| D19 |
Marzia Lo Russo |
Axillary duissection using a new ultrasonic device |
| D20 |
Paolo Pietrarota |
Sentinel node biopsy for T1-T2 breast cancer |
| D21 |
Charalambos Spyropoulos |
Sentinel node in male braest carcinoma |
| D22 |
Fabio Ricci |
Sentinel lymph node biopsy in breast cancer. The role od Day Surgery and local anaesthetic approach |
| D23 |
Osman Cem Yilmaz |
Intracystic breast cancer cases |
| D24 |
Osman Cem Yilmaz |
Primary cyst hydatid of the breast |
| D25 |
Toyokazu Aono |
Breast conservation surgery with latissimus dorsi muscular flap replacement |
| D26 |
Rana Nasr |
Location of the sentinel node in the axilla: is it predictable? |
| D27 |
Pornchai O-Charoenrat |
Quality of life in breast cancer survivors: comparative study of mastectomy alone, mastectomy with reconstruction and breast conserving surgery |
| E01 |
Khurshid Anwar |
Relationship between the socio-demographic factors and the clinicopathological characteristics with the intrinsic biomarkers of breast carcinoma of women in Pahang Malaysia |
| E02 |
Go See-Hoo |
Clinicopathologic factors affecting to actual 5-year survival rate in invasive ductal carcinoma of breast: a single-center experience with 365 patients |
| E03 |
Manar Atoum |
Comparison of plasma hormones between familial and non familial benign and breast cancer females |
| E04 |
Tea-hyun Kim |
Etrogen receptor α and β expression in breast cancer: relationship with clinicopathological oarameters and impact on clinical outcome |
| E05 |
Dalia Elfadl |
Antibody microarray technique identifies protein markers associated with radioresistance in breast and oral cancer cell lines |
| E06 |
Zina Garanina |
Proliferative cell nuclear antigen in patients with breast cancer |
| E07 |
Leonardo Cattelani |
Metaplastic carcinoma spindle-cell type of the breast |
| E08 |
Reem Salman |
Columnar celle lesions of the breast: a 5 years experience of a Breast Unit |
| E09 |
Aida Di Stefano |
Triple-negative breast cancer |
| E10 |
Giuseppe Viale |
Outcome prediction of the 70-gene mammaprint profile in endocrine responsive breast cancer patients as defined by the St. Gallen guidelines |
| E11 |
Femke De Snoo |
Mammaprint predicts survival in small breast cancer tumors |
| E12 |
Femke De Snoo |
The 70-gene mammaprint profile predicts chemotherapy benefit in early breast cancer |
| E13 |
Arianna Di Napoli |
The 70-gene prognosis signature as compared with traditionale pathological prognostic factors |
| E14 |
Iris de Morais Ferreira Bravo |
FDG-PET incidental diagnosisi of breast cancer in patient with prior Hodgkin lymphoma |
| E15 |
Iris de Morais Ferreira Bravo |
Primary breast lymphoma - A case report |
| E16 |
Jan Baak |
The regulation of apolipoprotein D gene expression in breast cancer cells |
| E17 |
Senad Secic |
Correlation clinical-pathological parameters and immunohistochemical expression protein nm23 in invasive breast cancer |
| E18 |
Querzoli Patrizia |
The 70 gene Mammaprint Tmsignature: a comparison with traditional clinico-pathological tools. |
| F1 |
Dario Francescatti |
Single fraction breast IORT utilizing xoft electronic brachytherapy |
| G1 |
Khalil Said |
Association of breast cancer, gastric gist and displaAssociation of breast cancer, gastric gist and displasia of colic mucosa: a case report |
| G2 |
Barbro Linderholm |
Identification of intermediate risk breast cancer patients (1-3 positive lymph nodes) with an excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers for proliferation and apoptosis |
| H1 |
Assia Bensalem |
Trastuzumab in adjuvant or metastatic breast cancer in three medical oncology centers in Algeria |
| H2 |
Gerald
Prudhomme |
Tranilast is an anti-cancer drug that inhibits multiple pathways and prevents breast cancer metastasis |
| H3 |
Daniele Generali |
Mammaprint: a new prognostic test for helping the oncologists in monitoring the pharmaceutical costs of their breast cancer patients |
| I1 |
Giovanni Giardina |
Primary endocrine therapy (PET) in elderly breast cancer patients |
| I2 |
Stankovic Dragomir |
Ulcerous breast cancer (UBC) |
| I3 |
Woo-Chan Park |
Treatment related acute myeloid leukemia in breast cancer: a single Institute experience in Korea |
| I4 |
Asanprakit
Wichitra |
A phase II study of neoadjuvant docetaxel followed by combination of Doxorubicin and Cyclophosphamide in locally advanced breast cancer patients: a preliminary report |
| RS1 |
Osman Cem Yilmaz |
Mastophobia |
| RS2 |
Immacolata Capasso |
Management of families with high risk of breast cancer. The National Cancer Institute of Naples experience |
| RS3 |
Immacolata Capasso |
A program of clinical-instrumental surveillance applied on women at higher risk for breast cancer: the National Cancer Institute of Naples experience |
| RS4 |
Marta Zaninelli |
A genetic counselling program for breast and ovarian cancer patients: focus on patient satisfaction |
